HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tristar

This article was originally published in The Rose Sheet

Executive Summary

Exec VP B.J. Harid to acting president and CEO following resignation of CEO Richard Howard to "pursue personal interests," company says. Howard served as CEO since December 1997, while Harid moved to management position in 2000 after serving on board of directors for four years. Harid likely will not be appointed to permanent post; search committee has been formed to review internal and external candidates. Howard's resignation follows 34.4% sales drop to $8.9 mil. in second quarter (ended Feb. 24). Decline attributed to "disappointing consumer sales industry wide." Net loss was $1.7 mil. for quarter, compared to deficit of $433,000 in prior-year period. Aggressive global distribution plan will be finalized in third quarter to strengthen revenue base and long-term growth potential

You may also be interested in...



Tristar

Beauty manufacturer announces plans to file for bankruptcy under Chapter 11 due to deteriorating financial condition that began one year ago, San Antonio, Texas firm says. Tristar, which plans to fill backlog of customer orders for 2001 holiday season, will reorganize and seek alternate sources of funding, according to CEO B.J. Harid. Firm delisted from NASDAQ Stock Market due to inability to file 10-Q with Securities and Exchange Commission for fiscal third quarter (ended May 26). Move follows reported sales of $8.9 mil. and net loss of $1.7 mil. in second quarter (1"The Rose Sheet" April 30, In Brief)

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009186

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel